Clinical Trial Update: Contrast-Enhanced Ultrasound in Predicting Treatment Response in Patients With Liver Cancer Receiving Transarterial Chemoembolization With Drug Eluting Beads [Phase 1]

View source ↗

Summary

A completed Phase 1 trial evaluating whether contrast-enhanced ultrasound can predict treatment response in hepatocellular carcinoma patients treated with drug-…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Hepatocellular Carcinoma

Drugs mentioned

• Doxorubicin (doxorubicin)

Snippet

Sponsor: Sidney Kimmel Comprehensive Cancer Center at Thomas Jefferson University | Conditions: Hepatocellular Carcinoma | Phase 1 | Status: COMPLETED